Article

Improved cataract surgery lowers infection rates

Endophthalmitis continues to be rare after cataract surgery, according to a study by Canadian researchers.

San Francisco-Endophthalmitis continues to be rare after cataract surgery, according to a study by Canadian researchers. Surgical techniques and patient selection criteria have evolved rapidly in the past several years and researchers wanted to learn whether infection risks were changing as a result.

Records were reviewed of more than 440,000 consecutive cataract surgeries performed in surgical facilities in Ontario, Canada between April 2002 and March 2006. Facilities where more than 50 cataract surgeries were performed were included.

Postoperative procedures to treat suspected infection that occurred within 14 days of cataract surgery were tracked by the study. The overall rate of suspected acute endophthalmitis was very low: 1.4 per 1,000 surgeries.

Patients who required correction of ruptures of their lens capsule during cataract surgery were about 10 times more likely to develop suspected infection, but fewer than 1 in 200 sustained such a rupture. The highest rate of suspected endophthalmitis occurred in patients aged 85 or more years (2.18 per 1,000).

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
© 2025 MJH Life Sciences

All rights reserved.